Zambian womenʹs attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIV

Use of mass nevirapine therapy—universal provision of the drug without HIV testing—for prevention of perinatal HIV in high prevalence settings with extreme resource constraints is a controversial strategy. A quarter of pregnant Zambian women surveyed would prefer to receive nevirapine through a non-testing mass strategy, and most would support mass therapy as a policy if it would make the drug available to a larger proportion of the at-risk population.